36,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
  • Broschiertes Buch

Discontinuation of, or outright defaulting on highly active antiretroviral therapy (HAART) by HIV-positive patients is harmful, and so is periodic unintentional non-adherence or treatment interruption. The resulting harm is especially more pronounced in sub-Saharan Africa where most individuals start HAART in advanced stages of the disease. Discontinuing patients could spread drug resistant virus to other individuals.

Produktbeschreibung
Discontinuation of, or outright defaulting on highly active antiretroviral therapy (HAART) by HIV-positive patients is harmful, and so is periodic unintentional non-adherence or treatment interruption. The resulting harm is especially more pronounced in sub-Saharan Africa where most individuals start HAART in advanced stages of the disease. Discontinuing patients could spread drug resistant virus to other individuals.
Autorenporträt
Ronald Kiguba is a Pharmacist, Epidemiologist, Biostatistician, and Lecturer at the Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences - Uganda. He was a visiting scholar at Clare College - University of Cambridge and at the Medical Research Council Biostatistics Unit, Institute of Public Health, Cambridge.